New technologies toward dendritic cell-based cancer immunotherapies

Related Experiment Video

Updated: Oct 7, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

H Matsue1, A Morita, K Matsue

  • 1Department of Dermatology, University of Texas, Southwestern Medical Center, Dallas 75235-9069, USA.

The Journal of Dermatology
|January 15, 2000
PubMed

Insights

Dendritic cells (DCs) are crucial for activating T cells and play key roles in immunity and cancer. This review explores recent advancements in DC-based immunotherapies for cancer prevention and treatment.

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • T cell activation relies heavily on specialized antigen-presenting cells, particularly dendritic cells (DCs).
  • DCs are present in tissues like the skin, encountering environmental antigens and pathogens.
  • DCs have demonstrated roles in both inflammatory diseases and protective immunity against infections and cancer.

Purpose of the Study:

  • To provide an overview of recent progress in dendritic cell-based immunotherapies.
  • To highlight the potential of DC-based strategies for cancer treatment and prevention.

Main Methods:

  • Review of current scientific literature on dendritic cell biology and immunotherapy.
  • Analysis of recent developments in the field of DC-based cancer therapies.

Main Results:

  • Dendritic cells are essential for initiating adaptive immune responses.
  • DC-based immunotherapies show promise for managing various cancers.
  • Understanding DC subsets and functions is key to developing effective treatments.

Conclusions:

  • Dendritic cell-based immunotherapies represent a significant area of advancement in oncology.
  • Further research into DC biology will likely yield improved therapeutic strategies for cancer.

More Related Videos

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...